Application 203756

Type
NDA
Sponsor
EXELIXIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001COMETRIQCABOZANTINIB S-MALATECAPSULE;ORALEQ 20MG BASEYesYes
002COMETRIQCABOZANTINIB S-MALATECAPSULE;ORALEQ 80MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42388-011COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-011COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-011COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-011COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-012COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-012COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-012COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-012COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-013COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-013COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-013COMETRIQcabozantinibExelixis, Inc.NDACurrent
42388-013COMETRIQcabozantinibExelixis, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83723SUPPL 2025-10-10
83712SUPPL 2025-10-09
75283SUPPL 2023-08-24
75275SUPPL 2023-08-24
69511SUPPL2021-12-07
65036SUPPL2020-10-27
64992SUPPL2020-10-23
61762SUPPL2020-02-04
61759SUPPL2020-02-03
51071SUPPL2018-01-17
51057SUPPL2018-01-17
49975SUPPL2017-10-06
49961SUPPL2017-10-06
32465SUPPL2016-05-24
40326SUPPL2016-05-23
43443ORIG2013-01-04
24448ORIG2013-01-04
40325ORIG2012-11-30
10248ORIG2012-11-30